¼¼°èÀÇ ¾Æ¸± źȭ¼ö¼Ò ¼ö¿ëü ½ÃÀå º¸°í¼­(2025³â)
Aryl Hydrocarbon Receptor Global Market Report 2025
»óǰÄÚµå : 1720717
¸®¼­Ä¡»ç : The Business Research Company
¹ßÇàÀÏ : On Demand Report
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 175 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 4,490 £Ü 6,319,000
PDF (Single User License) help
PDF º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 6,490 £Ü 9,134,000
PDF (Site License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ »ç¾÷ÀåÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 8,490 £Ü 11,949,000
PDF (Enterprise License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


¤± Add-on °¡´É: °í°´ÀÇ ¿äû¿¡ µû¶ó ÀÏÁ¤ÇÑ ¹üÀ§ ³»¿¡¼­ CustomizationÀÌ °¡´ÉÇÕ´Ï´Ù. ÀÚ¼¼ÇÑ »çÇ×Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.
¤± º¸°í¼­¿¡ µû¶ó ÃֽŠÁ¤º¸·Î ¾÷µ¥ÀÌÆ®ÇÏ¿© º¸³»µå¸³´Ï´Ù. ¹è¼Û±âÀÏÀº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

Çѱ۸ñÂ÷

¾Æ¸± źȭ¼ö¼Ò ¼ö¿ëü ½ÃÀå ±Ô¸ð´Â ÇâÈÄ ¼ö³â°£ °­·ÂÇÑ ¼ºÀåÀÌ ¿¹»óµÉ ¿¹Á¤ÀÔ´Ï´Ù. ¿¹Ãø ±â°£ÀÇ ¼ºÀåÀº ¿°Áõ¼º Áúȯ¿¡ÀÇ ÀÀ¿ëÀÇ È®´ë, â¾àÀÇ Áö¼ÓÀûÀÎ Áøº¸¿¡ ±âÀÎÇÑ´Ù°í »ý°¢µË´Ï´Ù.

ÀÚ°¡¸é¿ªÁúȯ°ú ¸¸¼ºÁúȯ Áõ°¡´Â ÇâÈÄ ¼ö³â°£ ¾Æ¸± źȭ¼ö¼Ò ¼ö¿ëü ½ÃÀåÀÇ ¼ºÀåÀ» °¡¼ÓÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ÀÌ·¯ÇÑ Áúº´ Áõ°¡´Â À¯Àü, ȯ°æ ¿µÇâ, ¶óÀÌÇÁ ½ºÅ¸ÀÏ º¯È­, Àå³» ȯ°æ ºÒ±ÕÇü, Áø´Ü ´É·Â Çâ»ó µîÀÇ ¿äÀΰú °ü·ÃÀÌ ÀÖ½À´Ï´Ù. ±×¸®°í ¸é¿ª ¼¼Æ÷ÀÇ ±â´É¿¡ ¿µÇâÀ» ¹ÌÄ¡´ÂÀÚ°¡ ¸é¿ª Áúȯ°ú ¸¸¼º Áúȯ¿¡ ´ëÇÑ Ä¡·á È¿°ú¸¦ Á¦°øÇÕ´Ï´Ù. ¿¹¸¦ µé¾î, 2023³â 7¿ù ½ºÄÚÆ²·£µå °øÁߺ¸°Ç±¹Àº 2022³â¿¡ »õ·Î Áø´ÜµÈ ´Ù¹ß¼º °æÈ­Áõ(MS) »ç·Ê°¡ Àü³âÀÇ 85.7%¿¡ ºñÇØ 87.2% Áõ°¡ÇÏ¿© 491°ÇÀÌ »õ·Î ±â·ÏµÇ¾î ÃÑ 6,359°ÇÀÌ µÇ¾ú´Ù°í º¸°íÇß½À´Ï´Ù.

¾Æ¸± źȭ¼ö¼Ò ¼ö¿ëü ½ÃÀåÀÇ ±â¾÷Àº ƯÁ¤ ¿°Áõ °æ·Î¸¦ Ç¥ÀûÀ¸·Î ÇÏ´Â ¿Ü¿ë¾à°ú °°Àº ÷´Ü Ä¡·á¹ýÀÇ °³¹ß¿¡ ÁÖ·ÂÇϰí ÀÖ½À´Ï´Ù. ±âÁ¸ ¼Ö·ç¼ÇÀ» Á¦°øÇÏ´Â µ¿½Ã¿¡ Àü½Å ºÎÀÛ¿ëÀ» ÃÖ¼ÒÈ­ÇÏ´Â °ÍÀÔ´Ï´Ù. ¿¹¸¦ µé¾î, 2022³â 5¿ù ¹Ì±¹ ±â¹Ý ¹ÙÀÌ¿À Á¦¾à ȸ»çÀÎ ´õ¸¶¹ÝÆ® »çÀ̾𽺴 ¹Ì±¹ ½ÄǰÀǾ౹(FDA)À¸·ÎºÎÅÍ 1% ŸÇdzª·ÎÇÁ(VTAMA) Å©¸²ÀÇ ½ÂÀÎÀ» ¹Þ¾Ò½À´Ï´Ù. VTAMA´Â 1ÀÏ 1ȸ µµÆ÷Çϵµ·Ï ¼³°èµÇ¾î Àü½Å¿¡ ´ëÇÑ Èí¼ö¸¦ ÃÖ¼ÒÈ­Çϸ鼭 ¾çÈ£ÇÑ ¾ÈÀü¼º ÇÁ·ÎÆÄÀÏÀ» ³ªÅ¸³»¸ç, ±âÁ¸ÀÇ Ä¡·áÁ¦¿Í´Â Àϼ±À» ¹¦»çÇϰí ÀÖ½À´Ï´Ù.

¸ñÂ÷

Á¦1Àå ÁÖ¿ä ¿ä¾à

Á¦2Àå ½ÃÀå Æ¯Â¡

Á¦3Àå ½ÃÀå µ¿Çâ°ú Àü·«

Á¦4Àå ½ÃÀå - °Å½Ã°æÁ¦ ½Ã³ª¸®¿À ±Ý¸®, ÀÎÇ÷¹À̼Ç, ÁöÁ¤ÇÐ, ½ÅÇü Äڷγª ¹ÙÀÌ·¯½º °¨¿°ÀÇ ¿µÇâ°ú ȸº¹ÀÌ ½ÃÀå¿¡ ¹ÌÄ¡´Â ¿µÇâÀ» Æ÷ÇÔÇÑ °Å½Ã°æÁ¦ ½Ã³ª¸®¿À

Á¦5Àå ¼¼°èÀÇ ¼ºÀå ºÐ¼®°ú Àü·« ºÐ¼® ÇÁ·¹ÀÓ¿öÅ©

Á¦6Àå ½ÃÀå ¼¼ºÐÈ­

Á¦7Àå Áö¿ªº°/±¹°¡º° ºÐ¼®

Á¦8Àå ¾Æ½Ã¾ÆÅÂÆò¾ç ½ÃÀå

Á¦9Àå Áß±¹ ½ÃÀå

Á¦10Àå Àεµ ½ÃÀå

Á¦11Àå ÀϺ» ½ÃÀå

Á¦12Àå È£ÁÖ ½ÃÀå

Á¦13Àå Àεµ³×½Ã¾Æ ½ÃÀå

Á¦14Àå Çѱ¹ ½ÃÀå

Á¦15Àå ¼­À¯·´ ½ÃÀå

Á¦16Àå ¿µ±¹ ½ÃÀå

Á¦17Àå µ¶ÀÏ ½ÃÀå

Á¦18Àå ÇÁ¶û½º ½ÃÀå

Á¦19Àå ÀÌÅ»¸®¾Æ ½ÃÀå

Á¦20Àå ½ºÆäÀÎ ½ÃÀå

Á¦21Àå µ¿À¯·´ ½ÃÀå

Á¦22Àå ·¯½Ã¾Æ ½ÃÀå

Á¦23Àå ºÏ¹Ì ½ÃÀå

Á¦24Àå ¹Ì±¹ ½ÃÀå

Á¦25Àå ij³ª´Ù ½ÃÀå

Á¦26Àå ³²¹Ì ½ÃÀå

Á¦27Àå ºê¶óÁú ½ÃÀå

Á¦28Àå Áßµ¿ ½ÃÀå

Á¦29Àå ¾ÆÇÁ¸®Ä« ½ÃÀå

Á¦30Àå °æÀï ±¸µµ¿Í ±â¾÷ ÇÁ·ÎÆÄÀÏ

Á¦31Àå ±âŸ ÁÖ¿ä ±â¾÷ ¹× Çõ½Å ±â¾÷

Á¦32Àå ¼¼°è ½ÃÀå °æÀï º¥Ä¡¸¶Å·°ú ´ë½Ãº¸µå

Á¦33Àå ÁÖ¿ä ÀμöÇÕº´(M&A)

Á¦34Àå ÃÖ±Ù ½ÃÀå µ¿Çâ

Á¦35Àå ½ÃÀåÀÇ ÀáÀç·ÂÀÌ ³ôÀº ±¹°¡, ºÎ¹®, Àü·«

Á¦36Àå ºÎ·Ï

KTH
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

The aryl hydrocarbon receptor is a protein that binds to environmental pollutants, such as dioxins, and regulates gene expression related to immune and inflammatory responses. It is used to modulate various biological processes, including the treatment of autoimmune and inflammatory conditions such as psoriasis, by selectively activating or inhibiting the receptor.

Key types of aryl hydrocarbon receptors include CB-993113, CDR-914K058, cinnabarinic acid, and others. CB-993113 is a small molecule inhibitor that targets the CBP/p300 bromodomain and is being studied for its potential to treat cancer and other diseases by modulating gene expression. These receptors and related compounds are distributed through various channels, such as direct sales, online platforms, distributors, retail pharmacies, and wholesale suppliers. They are used in treating conditions such as hepatocellular carcinoma, multiple sclerosis, obesity, and osteoporosis, and are applied across industries such as pharmaceuticals, biotechnology, agriculture, environmental consultancy, and research institutions.

The aryl hydrocarbon receptor market research report is one of a series of new reports from The Business Research Company that provides aryl hydrocarbon receptor market statistics, including the aryl hydrocarbon receptor industry global market size, regional shares, competitors with the aryl hydrocarbon receptor market share, detailed aryl hydrocarbon receptor market segments, market trends, and opportunities, and any further data you may need to thrive in the aryl hydrocarbon receptor industry. This aryl hydrocarbon receptor market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The aryl hydrocarbon receptor market size has grown strongly in recent years. It will grow from $4.64 billion in 2024 to $5.01 billion in 2025 at a compound annual growth rate (CAGR) of 8.1%. The growth during the historic period can be attributed to factors such as increased awareness of environmental toxins, expanded research in oncology, a surge in autoimmune disease studies, greater interest in targeted therapies, and the growing use of these therapies in drug development.

The aryl hydrocarbon receptor market size is expected to see strong growth in the next few years. It will grow to $6.79 billion in 2029 at a compound annual growth rate (CAGR) of 7.9%. The growth during the forecast period can be attributed to increased investment in precision medicine, rising demand for immunotherapy, a stronger focus on environmental health, expanding applications for inflammatory diseases, and continued advancements in drug discovery. Key trends in this period include progress in targeted cancer therapies, widespread adoption of precision medicine approaches, advancements in toxicology research, the integration of AI in drug discovery, and improvements in autoimmune disease treatments.

The increase in autoimmune diseases and chronic conditions is expected to drive the growth of the aryl hydrocarbon receptor (AHR) market in the coming years. Autoimmune diseases and chronic conditions are long-lasting disorders where the immune system malfunctions or health issues persist. The rise in these conditions is linked to factors such as genetics, environmental influences, lifestyle changes, gut imbalances, and improved diagnostic capabilities. AHR agonists have the potential to regulate immune responses and inflammation, offering therapeutic benefits for autoimmune diseases and chronic conditions by influencing T-cell differentiation and immune cell function. For example, in July 2023, Public Health Scotland reported that newly diagnosed cases of multiple sclerosis (MS) in 2022 increased by 87.2%, compared to 85.7% the previous year, with 491 new cases recorded, bringing the total to 6,359. As a result, the rise in autoimmune diseases and chronic conditions is propelling the growth of the AHR agonist market.

Companies in the AHR market are focusing on developing advanced treatments, such as topical medications that target specific inflammatory pathways. These treatments offer potential solutions for autoimmune diseases such as psoriasis, multiple sclerosis, and other chronic inflammatory conditions while minimizing systemic side effects. Topical medications are applied directly to the skin or mucous membranes to treat localized conditions or symptoms. For example, in May 2022, Dermavant Sciences, a US-based biopharmaceutical company, received approval from the U.S. Food and Drug Administration (FDA) for VTAMA (tapinarof) cream, 1%. This non-steroidal treatment option provides a unique mechanism of action through selective AHR modulation. Designed for once-daily application, VTAMA has shown a favorable safety profile with minimal systemic absorption, setting it apart from traditional therapies.

In September 2024, Organon & Co., a US-based pharmaceutical company, acquired Dermavant Sciences Ltd. for approximately $1.2 billion. This acquisition allows Organon to strengthen its dermatology portfolio by incorporating Dermavant's innovative dermatologic therapy, VTAMA (tapinarof) cream, 1%. Dermavant Sciences Ltd. specializes in developing AHR agonist-based therapies for dermatological conditions.

Major players in the aryl hydrocarbon receptor market are Bayer AG, Eli Lilly and Company, Organon & Co., Sigma-Aldrich Corporation, Bio-Techne Corporation, Abcam plc, R&D Systems Inc., Dermavant Sciences Inc., Cayman Chemical Company, Enzo Life Sciences Inc., Tocris Bioscience, Ikena Oncology Inc., MedChemExpress LLC, Hercules Pharmaceuticals BV, Active Biotech AB, AnTolRx Inc., Aqilion AB, Azora Therapeutics Australia Pty Ltd, Sol-Gel Technologies Ltd., and Actavalon Inc.

North America was the largest region in the aryl hydrocarbon receptor market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in aryl hydrocarbon receptor report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the aryl hydrocarbon receptor market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The aryl hydrocarbon receptor market consists of sales of synthetic AHR agonists, natural AHR agonists, AHR-targeted enzyme inhibitors, and pharmaceuticals targeting AHR pathways. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values and are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Aryl Hydrocarbon Receptor Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on aryl hydrocarbon receptor market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Where is the largest and fastest growing market for aryl hydrocarbon receptor ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The aryl hydrocarbon receptor market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

Scope

Table of Contents

1. Executive Summary

2. Aryl Hydrocarbon Receptor Market Characteristics

3. Aryl Hydrocarbon Receptor Market Trends And Strategies

4. Aryl Hydrocarbon Receptor Market - Macro Economic Scenario Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market

5. Global Aryl Hydrocarbon Receptor Growth Analysis And Strategic Analysis Framework

6. Aryl Hydrocarbon Receptor Market Segmentation

7. Aryl Hydrocarbon Receptor Market Regional And Country Analysis

8. Asia-Pacific Aryl Hydrocarbon Receptor Market

9. China Aryl Hydrocarbon Receptor Market

10. India Aryl Hydrocarbon Receptor Market

11. Japan Aryl Hydrocarbon Receptor Market

12. Australia Aryl Hydrocarbon Receptor Market

13. Indonesia Aryl Hydrocarbon Receptor Market

14. South Korea Aryl Hydrocarbon Receptor Market

15. Western Europe Aryl Hydrocarbon Receptor Market

16. UK Aryl Hydrocarbon Receptor Market

17. Germany Aryl Hydrocarbon Receptor Market

18. France Aryl Hydrocarbon Receptor Market

19. Italy Aryl Hydrocarbon Receptor Market

20. Spain Aryl Hydrocarbon Receptor Market

21. Eastern Europe Aryl Hydrocarbon Receptor Market

22. Russia Aryl Hydrocarbon Receptor Market

23. North America Aryl Hydrocarbon Receptor Market

24. USA Aryl Hydrocarbon Receptor Market

25. Canada Aryl Hydrocarbon Receptor Market

26. South America Aryl Hydrocarbon Receptor Market

27. Brazil Aryl Hydrocarbon Receptor Market

28. Middle East Aryl Hydrocarbon Receptor Market

29. Africa Aryl Hydrocarbon Receptor Market

30. Aryl Hydrocarbon Receptor Market Competitive Landscape And Company Profiles

31. Aryl Hydrocarbon Receptor Market Other Major And Innovative Companies

32. Global Aryl Hydrocarbon Receptor Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Aryl Hydrocarbon Receptor Market

34. Recent Developments In The Aryl Hydrocarbon Receptor Market

35. Aryl Hydrocarbon Receptor Market High Potential Countries, Segments and Strategies

36. Appendix

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â